Not logged in
Share
Save
Share
Save
Share
SavePPAR-γ agonist pioglitazone and the risks of malignancy among type2 diabetes mellitus patients
See, Lai-Chu; Wu, Chao-Yi; Tsai, Chung-Ying; Lee, Cheng-Chia; Chen, Jia-Jin; Jenq, Chang-Chyi; Chen, Chao-Yu; Chen, Yung-Chang; Yen, Chieh-Li; Yang, Huang-Yu
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
SaveCardiovascular, renal, and lower limb outcomes in patients with type 2 diabetes after percutaneous coronary intervention and treated with sodium-glucose cotransporter 2 inhibitors vs. dipeptidyl peptidase-4 inhibitors
Lee, Hsin-Fu; Chan, Yi-Hsin; Chuang, Chi; Li, Pei-Ru; Yeh, Yung-Hsin; Hsiao, Fu-Chih; Peng, Jian-Rong; See, Lai-Chu
Share
Save
Share
Save
Share
Save